Drugs / Fluval AB
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT01863849 | Aug → Sep 2013 | — | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| Phase 4 | NCT01649713 | Aug → Sep 2012 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| Phase 4 | NCT01404182 | Jul → Aug 2011 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| Phase not applicable2 trials · 1 met primary | ||||||
| — | NCT01408290 | Sep → Oct 2011 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| — | NCT01010893 | Aug → Sep 2009 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | Met primary |
| Comparator or background therapy2 trials | ||||||
| — | NCT01459276 Comparator | Oct → Dec 2011 | influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
| — | NCT01407978 Comparator | Aug 2009 → Mar 2010 | swine influenza | Fluart Innovative Vaccine Ltd, Hungary | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUVAL AB | “One 0.5 mL injection of FLUVAL AB trivalent influenza vaccine containing 15μgHA of seasonal A/H1N1, A/H3N2 and B influenza antigens.” NCT01459276 ↗ |
| Known as | Fluval AB influenza vaccine | “To assess immunogenicity of a single intramuscular (IM) injection of Fluval AB influenza vaccine (trivalent, seasonal, active ingredient content: 15 μg HA/0.5mL of seasonal...” NCT01404182 ↗ |
| Modality | Vaccine | “Fluval AB, a trivalent inactivated whole-virion influenza vaccine” PMID 20018367 ↗ Dec 2009 |
| Route | Intramuscular | “single intramuscular injection of Fluval AB suspension for injection” NCT01649713 ↗ |